Clinical Trial Update: Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating different doses of roxadustat for anemia in patients undergoing peritoneal dialysis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Peking University First Hospital | Conditions: Renal Anemia | Phase 4 | Status: COMPLETED